| NCT ID | NCT06756230 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saglik Bilimleri Universitesi |
| Condition | Idiopathic Pulmonary Fibrosis (IPF) |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-05-13 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-05-13 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study; will examine the effects of downhill walking (eccentric exercise training) on exercise capacity, quality of life, and blood lactate levels in individuals with IPF. After the initial assessment, patients will be randomized into two groups: downhill walking PR group and Standard PR Group.
Eligibility Criteria
Inclusion Criteria: * Having a diagnosis of IPF according to the clinical diagnostic criteria of the American Thoracic Society and/or the European Respiratory Society (ATS-ERS). * Being between the ages of 18 and 75. * Being able to walk on a treadmill. * Having the ability to cooperate. * No change in current medication in the last month. * Not participating in a structured activity program for at least six months. * Accepting the purpose and method of this study voluntarily and give informed consent for the study. Exclusion Criteria: * Presence of physical or mental impairment that prevents informed consent or compliance with the protocol. * Inability to attend more than 20% of pulmonary rehabilitation sessions. * Presence of major cardiovascular disease (coronary artery disease, uncontrolled hypertension, arrhythmias, or heart failure). * Presence of existing orthopedic and neuromuscular exercise limitations. * Acute exacerbation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06756230 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Idiopathic Pulmonary Fibrosis (IPF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06756230 currently recruiting?
Yes, NCT06756230 is actively recruiting participants. Contact the research team at fztesrakambur@yahoo.com for enrollment information.
Where is the NCT06756230 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06756230 clinical trial?
NCT06756230 is sponsored by Saglik Bilimleri Universitesi. The trial plans to enroll 34 participants.